The mammalian protooncogene homologue of the avian v-ets sequence from the E26 retrovirus consists of two sequentially distinct domains located on different chromosomes. Using somatic cell hybrid panels, we have mapped the mammalian homologue of the 5' v-ets-domain to chromosome 11 (ETSI) in man, to chromosome 9 (Ets-1) in mouse, and to chromosome D1 (ETSI) in the domestic cat. The mammalian homologue of the 3' v-ets domain was similarly mapped to human chromosome 21 (ETS2), to mouse chromosome 16 (Ets-2), and to feline chromosome C2 (ETS2). Both protooncogenes fell in syntenic groups of homologous linked loci that were conserved among the three species. The occurrence of two distinct functional protooncogenes and their conservation of linkage positions in the three mammalian orders indicate that these two genes have been separate since before the evolutionary divergence of mammals.
Transforming genes, or protooncogefles, represent a class of conserved cellular genes that may play an important role in tumorigenesis. They were initially described as transduced RNA segments in transforming retrovirus genomes, and they have also been discovered by focus induction after transfection of mouse 3T3 cells with genomic DNA extracted from human tumors (1) (2) (3) (4) (5) . The limited number of protooncogenes (%30) described to date has attracted considerable research emphasis as an experimental opportunity to study neoplastic transformation from both genetic and molecular perspectives. Because of these extensive analyses, there are now at least five documented modes of oncogene activation associated with tumorigenesis. These include the following: (i) transduction of portions of protooncogene transcripts by retroviruses, thereby placing the oncogene under regulatory control of strong promoters in the viral long terminal repeats (1) (2) (3) (4) (5) ; (ii) chromosomal insertion of an infecting retrovirus adjacent to a protooncogene, similarly altering their control of transcription (5, 6) ; (iii) translocation of cellular oncogenes to chromosomal regions of differential regulation (7, 8) ; (iv) amplification of oncogene-containing segments, thereby increasing the dosage of the oncogene (9) (10) (11) ; and (v) point mutation in the cellular coding sequence (2) .
The ets sequence was identified as a second cellular sequence transduced by the avian replication-defective retrovirus E26. The 5.7-kilobase (kb) RNA genome of E26 contains, in addition to partial retroviral gag and env genes, a part of the myb oncogene originally identified in avian myeloblastosis virus (AMV) and an E26-specific sequence, ets (12, 13 (18) (19) (20) . Hybrids were genetically characterized by G-trypsin banding (21), G-11 staining, and enzyme typing of [20] [21] [22] [23] [24] [25] [26] [27] [28] isozyme markers previously assigned to human chromosomes at the same passage from which high molecular weight DNA was extracted (20) . Genomic DNA was digested with restriction enzymes and subjected to a Southern analysis (22) using the specific v-ets, ets-1, and ets-2 probes described below (15, 17) . Analogous procedures were used to prepare and characterize the rodent-feline hybrid panel, which segregates cat chromosomes (23) , and the Chinese hamster-mouse panel, which segregates mouse chromosomes (24 (15) . E.1.28 contains 95% of the viral ets sequence (v-ets). Three human genomic clones that discriminate between c-ets-1 and c-ets-2 were used. The first two, pRD6K and pRD700, are human fragments derived from a single phage clone, RD3. pRD6K is a 5.7-kb EcoRI fragment; pRD700 is an 0.83-kb EcoRI fragment. Both pRD6K and pRD700 recognize human c-ets-J. The third human probe, H33, is a 1.02-kb EcoRI fragment that is specific for human c-ets-2. The three human clones share sequence homology with different regions of the viral ets sequence. From 5' to 3', the relative order in ets of homologous sequences is pRD6K-pRD700-pH33 (17) .
RESULTS
Human Protooncogene ETS1 Maps to Chromosome 11 and ETS2 Maps to Chromosome 21. To identify the human protooncogene homologues of v-ets, a nearly full-length v-ets molecular clone, E.1.28 ( Fig. 1A) , was nick-translated and used as a probe on nitrocellulose filters derived from a Southern analysis (22) of human and rodent DNAs. Fragments of 8.2, 6.2, 3.6, and 0.83 kb were detected following EcoRI digestion of human DNA (Fig. L4 ). The segregation of three of these fragments (8.2, 6.2, and 3.6 kb) was examined using DNAs from a panel of 50 somatic cell hybrids that had been genetically characterized by electrophoretic typing of previously assigned isozyme loci and by karyotype analysis using both G-11 and G-trypsin staining procedures (20, 21, 23) . These hybrids, which were prepared by PEG-mediated fusion of normal human lymphocytes with HPRT-resistant mouse (RAG) or Chinese hamster (E36) fibroblasts, retained the entire rodent genome but lost human chromosomes in different combinations.
Two of the human c-ets fragments produced by EcoRI digestion (6.2 and 8.2 kb) were concordantly retained or lost in the hybrid panel. The 3.6-kb fragment segregated independently of the others (Fig. LA) , suggesting that at least two chromosomes contained sequences homologous to v-ets. This result has been confirmed by the molecular cloning of two ets genes, the characterization and DNA sequences of which are discussed in detail elsewhere (17) . These studies have shown that distinct human loci are homologous to the 5' and 3' regions of the v-ets oncogene sequence. The two genes are both transcriptionally active, since they produce mRNA species of different sizes in several tissues (17) .
Subclones of human DNA sequences homologous to different portions of the v-ets gene were used in the mapping experiments. Clone H33, which is homologous to the 3' portion of v-ets, hybridized to the 3.6-kb human EcoRI fragment but not to the 0.83-, 6.2-, or 8.2-kb fragments (Fig.  1B) . Two additional cloned human sequences, pRD6K and pRD700, were shown to be homologous to contiguous 5' portions of v-ets. These probes recognized the EcoRI fragments of 6.2 and 0.83 kb, respectively, but did not crosshybridize with clone H33. The human DNA segment homologous to the 5' regions of v-ets, which is characterized by the 0.83/6.2-kb EcoRI pattern, is referred to as c-ets-1. The human locus homologous to the 3' region of v-ets, for which the 3.6-kb EcoRI fragment is diagnostic, is termed c-ets-2.
The chromosomal positions of ets-J and ets-2in the human genome were determined by correlating the presence of the diagnostic EcoRI fragments in the hybrid panels using both clone E.1.28 (v-ets) and clone H33 (ets-2-specific) as probes. The presence of the ets-J locus was 92-97% concordant with human chromosome 11 and the chromosome 11 isozyme markers LDHA and ACP2 but was highly discordant (33-58%) with each of the other human chromosomes (Fig.  2) . The presence of ets-2 was 100% concordant with the presence of human chromosome 21 and its isozyme marker, SOD] (Fig. 2B ). These data document that the ets-J protooncogene is located on chromosome 11 and that the ets-2 locus is on chromosome 21 . The assignment of ets-J to chromosome 11 is consistent with the recent study of de Taisne et al. (25) , who reported the assignment of an ets protooncogene to 11q23-24.
In situ hybridization of clone H33 (ets-2 specific) clone to normal human chromosome preparations confirmed the as- (Fig. 1C) . In Fig. 3 ) using both the v-ets (E.1.28) and the ets-2 (H33) clones as probes. The ets-1-specific pRD700 probe described above recognized only the 3.2-kb HindIII fragment (data not shown). The ets-2 specific human probe (H33) recognized both ets-1 and ets-2 murine homologues for reasons that were not immediately apparent. Nonetheless, the homology of H33 to the ets-1 locus in the mouse permitted the use of this probe in tracking the gene segregation in somatic cell hybrids. A previously characterized panel of mouse-Chinesehamster (E36) hybrids was used to study chromosome association of the murine ets loci (24) . These hybrids retain the entire Chinese hamster chromosomal complement but lose mouse chromosomes in different combinations. DNA was extracted from each of 16 hybrids concomitant with isozyme and karyologic analyses to determine the murine chromosome complement.
The murine DNA fragments segregated as two distinct loci in the hybrid panel (Fig. 3) . The Pst I fragment that is diagnostic for Ets-1 (7.8 kb) was 94% concordant with mouse chromosome 9 but discordant with the Ets-2 (2.9 and 9.8 kb)
segments and with each of the 19 other mouse chromosomes (30-70%; Fig. 2) . The 2.9-kb segment diagnostic forEts-2 was HindIll and hybridized with the human genomic pRD700 molecular clone, specific for ets-). The assignment of ets-2 to chromosome 21 in man and chromosome 16 in mouse represents the fifth homologous locus assigned to both of these chromosomes in the two species (26) . The map distance involved in this homologous syntenic group was determined by a linkage analysis between the Sod-i and ets-2 loci using restriction fragment length polymorphisms between inbred mouse strains. Briefly, DNA from several inbred mouse strains was examined with 14 restriction enzymes and two molecular probes: (i) an ets-2-specific 1.27-kb Pst I fragment that was homologous to H33 (Fig. lA) Assignment of Feline ETS1 to Chromosome D1 and ETS2 to Chromosome C2. The domestic cat homologues of the viral ets sequence were resolved following digestion of genomic DNA with Xba I and hybridization with one of two probes: (i) H33, specific for c-ets-2, and (ii) pRD700, specific for c-ets-1. The somatic cell hybrid panel used for the cat mapping was expanded and analyzed for chromosomal complement by the same strategies used in the human analysis (21, 23) .
Two Xba I fragments (6.8 and 11.0 kb) were detected in cat DNA and these segregated independently in the hybrid panel (Fig. 4) . As with the mouse homologues, both fragments were resolved with the H33 (human ets-2 specific) probe. The pRD700 probe, which is specific for human ets-1, preferentially detected the 4.0-kb band. This fragment was 96-100% concordant with feline chromosome D1 and its included markers LDHA, and ACP2 (Fig. 2) , but highly discordant (18-47%) with the 18 additional feline chromosomes. The appearance of the 11.0-kb Xba I feline fragment in the panel was 93-100% concordant with the presence of chromosome C2 and its isozyme markers, SOD] and GSR (glutathione reductase) but highly discordant (25-70%o) with other cat chromosomes. These data permit assignment of the ets-1 cat homologue to chromosome D1 and ofthe ets-2 cat homologue to chromosome C2.
DISCUSSION
At least three different prototype transforming retroviruses have been described that contain two distinct oncogenes encompassed by helper viral sequences. These include the avian carcinoma virus MH2, which contains v-myc and v-mht (also called mil; raf); avian erythroblastosis virus, which contains v-erbA and v-erbB; and the E26 virus, which contains v-myb and v-ets. We have reported here that the v-ets segment of E26 is derived from two domains that are themselves encoded on different chromosomes in mammals. with the human H33 probe, which is specific for ets-2 in man but hybridizes to both ets-1 and ets-2 fragments in cat and mouse. Hamster-feline hybrids were also digested with Xba I and hybridized with the human pRD700 probe, which is specific for ets-1 in man, mouse, and cat.
In addition to E26, two oncogenic viruses, Gardner-Rasheed feline sarcoma virus (GR-FeSV) and FBR murine sarcoma virus (FBR-MuSV), contain hybrid onc genes that include genetic elements from two different cellular genes and from essential retrovirus genes (27) (28) (29) . Diagnostic genomic clone probes for the two domains (termed ets-1 and ets-2) have been used to demonstrate transcriptional activity of both loci (17) and to chromosomally map the homologues in this study.
The genes overlap in a stretch of 14 amino acids in man (17) and have been assigned to chromosomes 11 and 21, respectively.
This dispersal of mammalian proto-ets sequences is in apparent contrast to organization in the chicken, from which the E26 virus was originally isolated. Avian c-ets has a genomic complex of 40-50 kb (15) that encodes a 7.5-kb ets mRNA (13, 17) . This single RNA transcript is resolved in RNA blots with both ets-1-and ets-2-specific probes, suggesting that the two domains are contiguous in the chicken genome. The biologically active viral ets mRNA is a truncated 1.5-kb version of the chicken message. Since v-ets is a rather small subset of the chicken proto-ets locus, as well as of the two mammalian c-ets loci, the relative contributions of the myb, ets-1, and ets-2 domains to viral transformation are not obvious.
With the recent rapid expansion of the human, murine, and feline gene maps, a more complete picture of chromosomal homologies between these species is emerging (30) . More than 100 homologous genes have been mapped in both mouse and man, and comparison of the two gene maps has revealed that considerable rearrangement has occurred since these species shared a common ancestor (26, 30, 31) . The cat has fewer mapped loci than the mouse, but the extent ofretention of homologous syntenic groups to man seems to be two to three times greater than between man and rodents (23, 30) . The ets-1 locus is mapped here to chromosome llq in man, to the chromosome 11 homologue in the cat (D1), and to the murine homologue of llq (chromosome 9). Fig. 5 (32) , mouse (33) , and cat (34) . The basis for homology of the genes included is discussed in refs. 26 and 30.
to the feline homologue, chromosome C2. The conservation of the linkage position of the two protooncogene domains in the same chromosomal positions in the three species indicates that their duality has persisted since the divergence of mammals began more than 100 million years ago.
Because the occurrence of specific translocations in human tumorigenesis has been shown to alter the cis regulation of adjacent protooncogene loci, the specific positions of such loci may be important. The same chromosome region that contains human ets-1 (11q23-24) has been reported to be involved in nonspecific translocations in acute myelogenous leukemia, as well as in Ewing sarcoma (25, 35, 36 
